ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DXR Daxor Corporation

9.5527
-0.121 (-1.25%)
11 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Daxor Corporation DXR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.121 -1.25% 9.5527 06:10:38
Open Price Low Price High Price Close Price Previous Close
9.67 9.49 9.67 9.5527 9.6737
more quote information »

Recent News

Date Time Source Heading
16/4/202422:00GLOBENew Studies Prove the Clinical Benefits of Daxor’s Blood..
15/4/202422:00GLOBEDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR..
10/4/202422:00GLOBEDaxor Corporation Announces New Hospital Account at Leading..
01/4/202423:00GLOBEDaxor Corporation to Exhibit at the American College of..
25/3/202423:00GLOBEDaxor Corporation Acquires Volumex® and Megatope® From Its..
22/3/202423:00GLOBEDaxor Corporation to Hold Investor Call Discussing Fiscal..
19/3/202405:18GLOBEDaxor Corporation CEO and President Michael Feldschuh..
11/3/202423:00GLOBEDaxor Announces Sales to Three New Hospitals Furthering..
09/3/202405:49EDGAR2Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of..
09/3/202400:00GLOBEMulti-Center Study Presented by Duke at Heart Failure..
07/3/202408:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202409:28EDGAR2Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of..
01/3/202408:15EDGAR2Form NT-NCSR - Notice under Exchange Act Rule 12b-25 of..
27/2/202400:00GLOBEDaxor Corporation to Exhibit at the Technology and Heart..
13/2/202400:00GLOBEDaxor Corporation Starts 2024 with Ongoing Growth in New..
08/2/202400:00GLOBEDaxor Corporation Closes Q4 2023 with Growth in New Sales to..
30/1/202400:00GLOBEDaxor Corporation to Exhibit at the Society of Nuclear..
17/1/202400:00GLOBEDaxor Corporation to Exhibit at the Society for Critical..
10/1/202400:00GLOBEDAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME..
03/1/202400:52EDGAR2Form 8-K - Current report
03/1/202400:30GLOBEDaxor Corporation Submits Dual 510(k)/CLIA-waiver..
07/12/202307:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202313:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202312:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202305:53EDGAR2Form NPORT-P - Monthly Portfolio Investments Report on Form..
25/11/202303:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202300:00GLOBENew Randomized Controlled Trial Demonstrates the Efficacy of..
13/11/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202300:00GLOBEDaxor Corporation Awarded New Patent for Remote Monitoring..
03/11/202309:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202308:27EDGAR2Form 8-K - Current report
17/10/202303:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202323:00GLOBEExpert Panelists Advocate Use of Daxor’s Technology to..
11/10/202323:00GLOBENew Data from Banner University Medicine Demonstrating..
04/10/202323:00GLOBEDaxor Corporation Awarded Support from the National..
27/9/202322:00GLOBEDaxor Corporation to Exhibit at the Heart Failure Society of..
26/9/202323:14EDGAR2Form 40-17G - Fidelity Bond [Rule 17G-1(g)]
26/9/202322:00GLOBEDAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR..
21/9/202306:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202302:00GLOBEDaxor Corporation Awarded $305K Grant from the National..
07/9/202323:15GLOBEDaxor Corporation to Present at the H.C. Wainwright 25th..
29/8/202306:15GLOBEDaxor Corporation CEO and President Michael Feldschuh..
29/8/202306:05GLOBEDaxor Corporation Reports a 20.64 Percent Increase in..
29/8/202306:01EDGAR2Form N-CSRS - Certified Shareholder Report, Semi-Annual
15/8/202321:14EDGAR2Form N-PX - Annual Report of proxy voting record of..
10/8/202322:00GLOBEJACC-HF Reports Successful Heart Failure Trial With Daxor..
14/7/202306:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/7/202306:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/7/202306:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..